Ambulatory Blood Pressure Monitors Market Size
Ambulatory Blood Pressure Monitors Market size is estimated to be valued at USD 1,955.3 Mn in 2025 and is expected to reach USD 3,438.9 Mn in 2032, exhibiting a compound annual growth rate (CAGR) of 8.4% from 2025 to 2032.
Key Takeaways
Market Overview
The global ambulatory blood pressure monitors market demand is gaining prominence driven by the comprehensive and accurate monitoring of a patient's blood pressure than traditional in-office measurements this approach helps to diagnose conditions like white coat hypertension and masked hypertension. It also helps in assessing the effectiveness of blood pressure medications and identifying potential risks associated with blood pressure fluctuation. The ambulatory blood pressure monitors are widely used in specific situations like pregnancy with hypertension, patients with fluctuating hypertension, or those with refractory hypertension.
Current Events and their Impact on the Ambulatory Blood Pressure Monitors Market
Current Event |
Description and its Impact |
Regulatory Developments Impacting Market Access |
|
Economic and Market Consolidation Trends |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Role of Artificial Intelligence (AI) on the Ambulatory Blood Pressure Monitors Market
The integration of artificial intelligence into ambulatory blood pressure monitors market offers significant potential for improving hypertension management. AI algorithms can analyze ABPM data, including patterns of blood pressure fluctuations, to enhance diagnosis, predict risks, and personalize treatment. This includes identifying hypertension, assessing nocturnal hypertension, and analyzing nocturnal dipping, potentially freeing up clinicians' time for more complex tasks. The use of artificial intelligence (AI) for interpreting ambulatory blood pressure monitoring (ABPM) data is gaining traction in clinical practice.
In March 2025, researchers at the Korea Advanced Institute of Science and Technology (KAIST) introduced a comprehensive framework for AI-driven wearable blood pressure sensors, aiming to revolutionize cardiovascular care. Published in Nature Reviews Cardiology, the work tackles technical and clinical hurdles—including signal degradation and accuracy—to enable continuous, non-invasive 24/7 monitoring via cuffless wearables.
Reimbursement Policy Expansions in Ambulatory Blood Pressure Monitors Market
The Centers for Medicare & Medicaid Services (CMS) has expanded Remote Patient Monitoring (RPM) reimbursement codes to include rural and underserved clinic networks. This update allows qualified healthcare providers to claim up to $288 per patient per month for ABPM-related services. As a result, analysts anticipate a 31% surge in home-based ABPM device deployments across the U.S., particularly in areas with limited access to traditional diagnostic infrastructure. This expansion is pivotal for early hypertension detection and aligns with broader public health strategies aimed at reducing cardiovascular risk in rural populations.
In Japan, recent reforms under its national health insurance policy now include coverage for remote ABPM devices under telemedicine services. This update is expected to unlock the market opportunity, particularly in highly urbanized and tech-forward regions such as Osaka and Tokyo. By allowing physicians to monitor patients remotely, these reforms not only improve chronic disease management but also reduce hospital visits and related costs. The integration of ABPM into Japan’s telehealth model underscores a growing shift toward personalized, preventive care in advanced economies.
Together, these policy moves signify a structural shift in how chronic disease diagnostics are reimbursed and deployed, positioning ABPM as a frontline tool in hypertension and cardiovascular disease prevention globally.
Ambulatory Blood Pressure Monitors Market Insights, Product Type
Wrist Monitors Acquires the Largest Market Share Owing to its High Sensitivity and Reliable Reading
In terms of product type, the wrist monitors segment is expected to contribute 56.8% share of the market in 2025 owing to its high sensitivity and reliable reading. The wrist blood pressure monitors primarily centered around convenience and portability. They are generally smaller, lighter, and more discreet than traditional upper arm monitors, making them ideal for travel and on-the-go use. Additionally, wrist monitors can be more comfortable for individuals with larger arms or those who find the pressure of an upper arm cuff uncomfortable. Some wrist blood pressure monitors may be accurate when used exactly as directed and checked against measurements taken in a medical office.
In June 2025, according to IDC’s Worldwide Quarterly Wearable Device Tracker, Huawei claimed the No. 1 spot in the global wrist-worn device market during Q1 2025, driven by strong growth and dominance in China. The milestone also marked 200 million cumulative shipments worldwide as of June 5. Huawei’s diverse portfolio including Watch 5, Watch Fit 4 Pro, GT series, and blood-pressure-enabled Watch D, cater to users across smart-living, fitness, health, and professional-use scenarios. The company’s upgraded TruSense system enhances vital-sign accuracy, reflecting Huawei’s commitment to smart healthcare and wearable innovation.
Ambulatory Blood Pressure Monitors Market Insights, End User
Hospital Dominates the Overall Market
In terms of end user, the hospital segment is projected to contribute the highest share of the market in 2025, driven by ability to assess a patient's overall health, identify potential problems, and guide treatment decisions. Blood pressure measurements are crucial for diagnosing and managing conditions like hypertension (high blood pressure) and hypotension (low blood pressure), and for monitoring the effectiveness of treatments. Checking the blood pressure at hospitals is essential as it can determine any signs of underlying medical conditions such as heart disease, stroke risk internal bleeding, or dehydration. Blood pressure readings also play a key role in managing chronic illnesses such as diabetes, kidney disease, and heart failure, allowing healthcare providers to make informed decisions about medications and treatment plans. Regular monitoring helps in preventing serious complication by enabling early intervention when slight abnormal values are detected.
In May 2025, Katz Women’s Hospital at LIJMC launched a specialized cardiology program addressing women’s heart health, focusing on the diagnosis and treatment of Ischemia with Non-Obstructive Coronary Arteries (INOCA)—a condition where women experience chest pain without major artery blockages. This is further anticipated to add to the ambulatory blood pressure monitors market share.
Regional Insights
To learn more about this report, Request sample copy
North America Ambulatory Blood Pressure Monitors Market Analysis & Trends
North America is estimated to be the largest market for ambulatory blood pressure monitors during the forecast period, accounting for over 36.30% of the market share in 2025. The market growth in North America is due to the increasing prevalence of hypertension and rising awareness about advanced ambulatory monitors. Hypertension affects nearly one in four Canadian adults between the ages of 20 and 79. This is further accelerating the ambulatory blood pressure monitors market growth.
The growing geriatric population, who are more susceptible to hypertension. According to recent ambulatory blood pressure monitors market research, a recent primary-care report revealed growing use of ABPM as a point-of-care diagnostic tool, including pediatric hypertension detection—highlighting broader clinical acceptance. As both public health initiatives and provider infrastructure support expanded ABPM use, North America remains the clear leader, while home-based monitoring continues to gain traction under evolving reimbursement and telehealth frameworks.
Asia Pacific Ambulatory Blood Pressure Monitors Market Analysis & Trends
Asia Pacific is the fastest-growing market for cervical cancer vaccines. The Asia Pacific region represents a major opportunity for market players in the ambulatory blood pressure monitors industry. With rising healthcare expenditures and a growing focus on preventive healthcare, the demand for blood pressure monitoring devices is increasing rapidly across several countries. For instance, by 2035, government health spending per person in India is expected to rise to USD 62.84. China and India are expected to be the fastest growing markets due to their huge patient bases and improving access to diagnostic services. Growing awareness about hypertension and its management. The ambulatory blood pressure monitors market forecast indicates the incorporation of governments in the region expanding diagnostic infrastructure and promote remote monitoring, deployment of home and clinic-based ABPM devices is accelerating—strengthening the market outlook in China, India, and beyond.
Ambulatory Blood Pressure Monitors Market Outlook Country-Wise
The United States Ambulatory Blood Pressure Monitors Market
The U.S. ambulatory blood pressure monitors market is characterized by high prevalence of hypertension, the need to accurately diagnose hypertension, and the desire to optimize treatment strategies. In the United States, nearly half of all adults (approximately 119.9 million) have hypertension, also known as high blood pressure. This condition is a major risk factor for heart disease and stroke, which are leading causes of death. According to Centers for Disease Control and Prevention, nearly 48% of U.S. adults has hypertension in 2023.
In January 2025, the American Heart Association (AHA) and American Medical Association (AMA) relaunched their Target:BP™ Initiative, aiming to improve hypertension outcomes for over 9 million Americans. The campaign focuses on four pillars: accurate blood pressure measurement, timely clinical intervention, self‑measured patient monitoring, and patient partnership.
India Ambulatory Blood Pressure Monitors Market
India ambulatory blood pressure monitors market is experiencing significant growth in recent years, driven by public health insurance schemes. Pradhan Mantri Jan Arogya Yojana (PM-JAY), is set to add 500 million newly insured beneficiaries, triggering a significant surge in demand for cost-effective diagnostic tools. Among these, Ambulatory Blood Pressure Monitoring (ABPM) devices—used for diagnosing and managing hypertension—are expected to see a dramatic uptick, especially under the program’s cost-efficiency mandates.
Additionally, with a strict price ceiling of USD 150 (approx. ₹12,500) per device for reimbursement eligibility, domestic medical technology manufacturers are now focusing on producing low-cost, rugged, and user-friendly ABPM solutions tailored to rural and semi-urban healthcare settings. The expansion not only amplifies access to advanced cardiovascular monitoring tools but also encourages local innovation and scaled production under India’s "Make in India" healthcare initiative.
Market Report Scope
Ambulatory Blood Pressure Monitors Market Report Coverage
Report Coverage | Details | ||
---|---|---|---|
Base Year: | 2024 | Market Size in 2025: | USD 1,955.3 Mn |
Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
Forecast Period 2025 to 2032 CAGR: | 8.4% | 2032 Value Projection: | USD 3,438.9 Mn |
Geographies covered: |
|
||
Segments covered: |
|
||
Companies covered: |
OSI Systems Inc., SunTech Medical Inc., Andon Health Co. Ltd., Schiller AG, Omron Healthcare Co. Ltd., Beurer GmBH, Finapres Medical Systems B.V., Welch Allyn, Inc., Koninklijke Philips N.V., Aktiia, Biobeat, LiveMetric, CardiAI Inc |
||
Growth Drivers: |
|
||
Restraints & Challenges: |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Global Ambulatory Blood Pressure Monitors Market Trends
Global Ambulatory Blood Pressure Monitors Market Drivers
Global Ambulatory Blood Pressure Monitors Market Opportunities
Key Developments
Analyst Opinion (Expert Opinion)
The Ambulatory Blood Pressure Monitors (ABPM) market value is entering a strategic inflection point—not due to sheer demand volume, but because of regulatory decentralization, payer shifts, and technology redefinition. The clinical superiority of ABPM in detecting white-coat hypertension and nocturnal dipping patterns has been established for over a decade, yet its real market unlock is just beginning, driven by payer-led remote monitoring initiatives and a decisive move away from in-clinic blood pressure assessments.
The Centers for Medicare & Medicaid Services (CMS) has already catalyzed adoption by expanding coverage for ABPM under Remote Physiologic Monitoring (RPM) codes, particularly targeting rural clinics and patients with episodic hypertension. This is not a marginal change—it structurally alters how blood pressure is managed in hypertensive populations. According to the American Heart Association, over 20% of diagnosed hypertension cases are white-coat in nature. ABPM is now a clinical and reimbursement imperative, not a luxury.
Private insurers are following suit. UnitedHealthcare and Blue Cross Blue Shield have introduced performance-based reimbursement models where ABPM outcomes—especially in resistant hypertension—determine continuity of coverage for medication plans. In essence, the payer system is coercing clinical decision-making toward ABPM validation.
Technologically, the market is bifurcating into traditional cuff-based ABPMs and cuffless, wearable-enabled continuous monitoring devices. While cuff-based systems like Spacelabs and Welch Allyn dominate the clinical segment, startups like Sky Labs (Korea) and Aktiia (Switzerland) are defining algorithm-driven, cloud-connected ABPMs with high-frequency sampling. For instance, Sky Labs’ CART-I ring has been validated in multi-country trials and shows promising convergence between wearability and accuracy, with 91.4% correlation against standard ABPMs in a 2024 peer-reviewed study.
The biggest overlooked force? Electronic Health Record (EHR) integration. Devices that offer FHIR-compatible APIs are becoming default choices in hospital purchasing cycles. In the U.S., more than 70% of hospitals require remote patient monitoring devices to sync with Epic or Cerner, and this is creating a data gravity effect, where a handful of monitor OEMs are absorbing institutional demand due to EHR-compatibility alone.
Market Segmentation
Sources
Primary Research Interviews from the following stakeholders
Stakeholders
Databases
Magazines
Journals
Newspapers
Associations
Public Domain Sources
Proprietary Elements
Definition: Ambulatory blood pressure monitoring (ABPM) involves measuring a patient's blood pressure at regular intervals over a 24-hour period by using a portable monitor. There are two main types of ambulatory blood pressure monitors - wrist ABPM devices and arm cuff ABPM devices. Wrist ABPM devices are worn on the wrist like a watch and non-invasively measure blood pressure through the wrist. Arm cuff ABPM devices utilize a standard blood pressure cuff that is worn on the upper arm. These devices automatically inflate and measure blood pressure at preset time intervals.
Share
Share
About Author
Komal Dighe is a Management Consultant with over 8 years of experience in market research and consulting. She excels in managing and delivering high-quality insights and solutions in Health-tech Consulting reports. Her expertise encompasses conducting both primary and secondary research, effectively addressing client requirements, and excelling in market estimation and forecast. Her comprehensive approach ensures that clients receive thorough and accurate analyses, enabling them to make informed decisions and capitalize on market opportunities.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our ClientsUS Reciprocal Tax Impact Analysis On Ambulatory Blood Pressure Monitors Market
Stay updated on tariff changes with expert insights and timely information